Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 25, 2022 4:00 P.M.
Form: S-3
CIK: 0000891293
Company Name: CTI BIOPHARMA CORP
File Number: 333-266926